Filter posts

BIO CEO & Investor Conference Kicks Off in NYC

The 17th Annual BIO CEO & Investor Conference opened today with a record number of partnering …

How Industry Rates Interactions with the FDA

Kicking off day one of the BIO CEO & Investor Conference in New York City, …

Patients Remain the Focus for the Future of Personalizing Oncology

The 17th Annual BIO CEO & Investor Conference, being held at the Waldorf Astoria in New …

J.P. Morgan Turns All Eyes toward Biotech

BioWorld’s Peter Winter reports that the mood is upbeat at today’s kickoff of the 33rd …

Rep. Upton and DeGette Will Discuss 21st Century Cures Initiative at BIO CEO

The biotech industry answers the call for 21st Century Cures to revolutionize the drug development …

Rare Disease Day 2014: Joining Together for Better Care

There are more than 6,000 different rare diseases affecting over 60 million people across Europe …

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, …

#BIOCEO14: An Optimistic Outlook for 2014

The 16th Annual BIO CEO & Investor Conference​ concluded with a lively Closing Plenary Session examining …

4 Tips for Building a Successful Biotech: Richard Pops of Alkermes at #BIOCEO14

The 16th Annual BIO CEO & Investor Conference opened with a fireside chat between Richard …

Biotech Investors, Emerging Companies Bullish On 2014

The 16th BIO CEO & Investor Conference is off to a great start. This event …